Institute for Neurodegenerative Disorders (034) — New Haven, Connecticut

Institute for Neurodegenerative Disorders (034) is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Institute for Neurodegenerative Disorders (034) has participated in 1 clinical trials.

Therapeutic areas: Early Parkinson Disease.

Sponsors: Neurogen Corporation.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute for Neurodegenerative Disorders (034)?

Institute for Neurodegenerative Disorders (034) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute for Neurodegenerative Disorders (034) conducted?

Institute for Neurodegenerative Disorders (034) has 1 clinical trials on record. Their work covers Early Parkinson Disease.

Is Institute for Neurodegenerative Disorders (034) accredited by Crixeo Health?

Institute for Neurodegenerative Disorders (034) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute for Neurodegenerative Disorders (034)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.